Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantation.

Rozmus, Jacob; McDonald, Rachel; Fung, Shan-Yu; Del Bel, Kate L; Roden, Juliana; Senger, Christof; Schultz, Kirk R; McKinnon, Margaret L; Davis, Jeffrey; Turvey, Stuart E

Rozmus, Jacob; McDonald, Rachel; Fung, Shan-Yu; Del Bel, Kate L; Roden, Juliana; Senger, Christof; Schultz, Kirk R; McKinnon, Margaret L; Davis, Jeffrey; Turvey, Stuart E.

Afiliación

Rozmus J; Department of Pediatrics, BC Children's Hospital, Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
McDonald R; Department of Pediatrics, BC Children's Hospital, Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
Fung SY; Department of Pediatrics, BC Children's Hospital, Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
Del Bel KL; Department of Pediatrics, BC Children's Hospital, Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
Roden J; Department of Pediatrics, BC Children's Hospital, Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
Senger C; Pathology and Laboratory Medicine, BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
Schultz KR; Department of Pediatrics, BC Children's Hospital, Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
McKinnon ML; Medical Genetics, Child & Family Research Institute, BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
Davis J; Department of Pediatrics, BC Children's Hospital, Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
Turvey SE; Department of Pediatrics, BC Children's Hospital, Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada. Electronic address: sturvey@cw.bc.ca.

Clin Immunol ; 168: 1-5, 2016 07.

Article en En | MEDLINE | ID: mdl-27109639

ABSTRACT

ABSTRACT

MALT1 mutations impair normal NF-κB activation and paracaspase activity to cause a novel combined immunodeficiency. The clinical and immunological phenotype of MALT1 deficiency can be successfully treated with hematopoietic stem cell transplantation following reduced intensity conditioning.

Asunto(s)

Caspasas/genética; Trasplante de Células Madre Hematopoyéticas/métodos; Síndromes de Inmunodeficiencia/terapia; Mutación; Proteínas de Neoplasias/genética; Adolescente; Caspasas/deficiencia; Caspasas/metabolismo; Células Cultivadas; Humanos; Síndromes de Inmunodeficiencia/genética; Síndromes de Inmunodeficiencia/metabolismo; Leucocitos Mononucleares/metabolismo; Proteína 1 de la Translocación del Linfoma del Tejido Linfático Asociado a Mucosas; FN-kappa B/metabolismo; Proteínas de Neoplasias/deficiencia; Proteínas de Neoplasias/metabolismo; Transducción de Señal; Resultado del Tratamiento

Palabras clave

CARD11BCL10MALT1 (CBM) signalosome complex; Combined immunodeficiency; Hematopoietic stem cell transplantation (HSCT); MALT1 mutations; NF-κB; Paracaspase

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Caspasas / Síndromes de Inmunodeficiencia / Mutación / Proteínas de Neoplasias Límite: Adolescent / Humans Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google